Prognosis impact of ticagrelor vs clopidogrel based DAPT discontinuation after acute coronary syndrome. Insights from the multicenter CREA ARIAM Andalucia registry

Back

ACVC Premium Access

Prognosis impact of ticagrelor vs clopidogrel based DAPT discontinuation after acute coronary syndrome. Insights from the multicenter CREA ARIAM Andalucia registry

Session: Acute Coronary Syndromes: Platelets, Lipids, Techniques and Systems

Topic: Thrombosis, Platelets, and Coagulation

Speaker: Doctor G. Padilla Rodriguez (Seville, ES)

Event: ESC Acute CardioVascular Care 2022

Congress Presentation

Add to my library

About the speaker

Doctor Gloria Rocio Padilla Rodriguez

University Hospital of Virgen Macarena, Seville (Spain)

0 follower

7 more presentations in this session

Acute coronary syndromes in young patients and thrombophilia : the experience of our hospital

Speaker: Doctor E. Bachlitzanaki (Heraklion, GR)

Comparative safety and effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndrome. An on treatment analysis from the multicenter CREA ARIAM Andalucia registry

Speaker: Mrs B. Hernandez-Meneses (Seville, ES)

Can we predict the coronary angiography result?

Speaker: Doctor M. Santos (Barreiro, PT)

Percutaneous coronary intervention for true bifurcation lesions: a single-center experience including the setting of acute coronary syndromes

Speaker: Doctor M. Brandao (Vila Nova de Gaia, PT)

Prognostic impact of anemia in acute coronary syndrome patients

Speaker: Doctor P. Rocha Carvalho (Vila Real, PT)

Access the full session

Acute Coronary Syndromes: Platelets, Lipids, Techniques and Systems

Speakers: Doctor G. Padilla Rodriguez, Doctor E. Bachlitzanaki, Mrs B. Hernandez-Meneses, Doctor M. Santos, Doctor M. Brandao...

Access

About the event

ESC Acute CardioVascular Care 2022

18 March - 19 March 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources